deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT03648970

Indonesia Pravastatin to Prevent Preeclampsia Study (INOVASIA)

Pravastatin to Prevent Preeclampsia and Reduce Maternal-Neonatal Mortality and Morbidity in High Risk Preeclampsia Patients

Sponsor: Universitas Airlangga

Conditions Pre-Eclampsia
Interventions Pravastatin
Updated 5 times since 2018 Last updated: Aug 23, 2018 Started: Mar 1, 2018 Primary completion: Mar 1, 2020 Completion: Dec 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Pre-Eclampsia, this trial is ongoing. The trial is conducted by Universitas Airlangga and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  5. Sep 2018 — Jan 2021 [monthly]

    Recruiting PHASE2

    First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universitas Airlangga
Data source: Universitas Airlangga

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations